Atlas Trials

Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis

Clinical trial NCT00152412 · COMPLETED

Trial details

NCT number
NCT00152412
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2004-06-01
Primary completion
2004-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.